Sana Biotechnology Inc (SANA) Stock Price, Quote & News

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology

Sector: Healthcare

Phone: 206 701 7914

Website: www.sana.com

Address:

188 East Blaine Street, Suite 400, Seattle, United States

SKIJK May. 15 at 1:11 AM

$SANA MAYO Clinic buying 15 million shares. I believe at $3.30, Time to BUY!

0 · Reply

mastergambler May. 14 at 7:08 PM

$SANA dilution, dilution, and dilution...

2 · Reply

BBraggHillBoys May. 14 at 7:06 PM

$SANA is this a scam as some suggest here or: hypoimmune engineering, stem cell derived therapies, delivery systems, and regenerative medicine all in one platform thesis?

0 · Reply

brut_2_3 May. 14 at 6:53 PM

$SANA Anyone have any thoughts on the high volume today? It seems like almost 10x more than normal.

0 · Reply

BBraggHillBoys May. 14 at 6:46 PM

$SANA punishing the uncertainty that still lingers

0 · Reply

red1 May. 14 at 6:33 PM

$SANA anyone know why the volume is so high with real price movement?

2 · Reply

Harold2029 May. 14 at 6:28 PM

$SANA This should STILL be at least $30 …. The prospects of a remedy for Diabetes and its at: $3.10? You’ve GOT TO BE KIDDING ME!

0 · Reply

brut_2_3 May. 14 at 6:22 PM

$SANA Added some more today. Total holding now at 85k shares. Pretty much all my money is in this play. Been waiting patiently for years — hopefully one day it all pays off and the fruits come through.

1 · Reply

Harold2029 May. 14 at 5:41 PM

$SANA …. MAYO Clinic buying 15 million shares. Some analyst is predicting a 100x. Find a remedy for diabetes and you get the 100x. Im in! GLTA.

0 · Reply

FullTrust May. 14 at 2:01 PM

$SANA 20 mil vol hit tape at open So diluting or monster in the making

4 · Reply

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

May 12, 2026, 5:20 PM EDT - 2 days ago

Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 4:05 PM EDT - 2 days ago

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

2026-05-11T20:42:28.000Z - 3 days ago

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

May 11, 2026, 4:05 PM EDT - 3 days ago

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

2026-05-11T17:02:47.000Z - 3 days ago

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

2026-05-08T18:45:07.000Z - 6 days ago

Sana Biotechnology options imply 5.3% move in share price post-earnings

May 5, 2026, 4:05 PM EDT - 9 days ago

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Apr 27, 2026, 4:30 PM EDT - 17 days ago

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

2026-04-14T13:23:10.000Z - 4 weeks ago

Sana Biotechnology price target raised to $7 from $6 at Wedbush

2026-04-13T20:18:08.000Z - 4 weeks ago

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

2026-03-13T13:10:51.000Z - 2 months ago

Sana announces follow-up results from first-in-human study transplanting UP421

Mar 11, 2026, 1:40 PM EDT - 2 months ago

Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026

2026-03-03T22:25:38.000Z - 2 months ago

Sana Biotechnology files automatic mixed securities shelf

2026-03-03T21:25:24.000Z - 2 months ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

Mar 3, 2026, 4:05 PM EST - 2 months ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Mar 2, 2026, 1:10 PM EST - 2 months ago

Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference

Feb 23, 2026, 4:05 PM EST - 2 months ago

Sana Biotechnology to Present at March 2026 Investor Conferences

2026-02-17T14:16:15.000Z - 3 months ago

Sana Biotechnology appoints Piper as EVP, CFO

Jan 14, 2026, 12:45 PM EST - 4 months ago

Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 4:26 PM EST - 4 months ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

2026-01-06T15:25:24.000Z - 4 months ago

Sana Biotechnology price target raised to $7 from $6 at BofA

2025-12-08T14:05:59.000Z - 5 months ago

Sana Biotechnology announces publication of in vivo gene editing

Dec 8, 2025, 9:00 AM EST - 5 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 3, 2025, 2:35 PM EST - 5 months ago

Sana Biotechnology Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 2, 2025, 2:30 PM EST - 5 months ago

Sana Biotechnology Transcript: Citi Annual Global Healthcare Conference 2025

Nov 24, 2025, 4:05 PM EST - 6 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 12, 2025, 1:30 PM EST - 6 months ago

Sana Biotechnology Transcript: TD Cowen Immunology and Inflammation Summit

2025-11-06T23:25:54.000Z - 6 months ago

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

2025-11-06T20:25:18.000Z - 6 months ago

Sana Biotechnology options imply 17.5% move in share price post-earnings

2025-10-30T10:25:41.000Z - 7 months ago

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

2025-10-15T17:45:20.000Z - 7 months ago

Sana Biotechnology strength attributed to EMJ Capital long call

2025-09-24T11:45:09.000Z - 8 months ago

Wedbush bullish on Sana Biotechnology, initiates with an Outperform

2025-09-24T10:50:09.000Z - 8 months ago

Sana Biotechnology initiated with an Outperform at Wedbush

Sep 9, 2025, 9:30 AM EDT - 8 months ago

Sana Biotechnology Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 11:30 AM EDT - 8 months ago

Sana Biotechnology Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 8:00 AM EDT - 9 months ago

Sana Biotechnology Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 2, 2025, 3:15 PM EDT - 9 months ago

Sana Biotechnology Transcript: Citi's Biopharma Back to School Conference

Aug 28, 2025, 8:00 AM EDT - 9 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Aug 26, 2025, 4:05 PM EDT - 9 months ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 20, 2025, 4:05 PM EDT - 9 months ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

2025-08-11T20:55:26.000Z - 9 months ago

Sana Biotechnology reports Q2 EPS (16c), consensus (21c)

2025-08-08T17:05:14.000Z - 9 months ago

Sana Biotechnology options imply 10.8% move in share price post-earnings

Aug 6, 2025, 11:24 PM EDT - 10 months ago

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 4:38 PM EDT - 10 months ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 7:00 AM EDT - 10 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Aug 4, 2025, 11:35 AM EDT - 10 months ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Jun 23, 2025, 10:05 AM EDT - 11 months ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 10, 2025, 8:40 AM EDT - 1 year ago

Sana Biotechnology Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 4, 2025, 2:35 PM EDT - 1 year ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2025

May 28, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at June 2025 Investor Conferences

May 13, 2025, 12:20 PM EDT - 1 year ago

Sana Biotechnology Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

Mar 17, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Mar 3, 2025, 3:10 PM EST - 1 year ago

Sana Biotechnology Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 24, 2025, 4:05 PM EST - 1 year ago

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

Jan 15, 2025, 12:00 PM EST - 1 year ago

Sana Biotechnology Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 8, 2025, 4:05 PM EST - 1 year ago

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 7:25 AM EST - 1 year ago

This Biotech Stock Just Soared 240%. Why It Can Go Higher.

Jan 7, 2025, 4:30 PM EST - 1 year ago

Sana Biotechnology Transcript: Study Result

Jan 7, 2025, 4:05 PM EST - 1 year ago

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

SKIJK May. 15 at 1:11 AM

$SANA MAYO Clinic buying 15 million shares. I believe at $3.30, Time to BUY!

0 · Reply

mastergambler May. 14 at 7:08 PM

$SANA dilution, dilution, and dilution...

2 · Reply

BBraggHillBoys May. 14 at 7:06 PM

$SANA is this a scam as some suggest here or: hypoimmune engineering, stem cell derived therapies, delivery systems, and regenerative medicine all in one platform thesis?

0 · Reply

brut_2_3 May. 14 at 6:53 PM

$SANA Anyone have any thoughts on the high volume today? It seems like almost 10x more than normal.

0 · Reply

BBraggHillBoys May. 14 at 6:46 PM

$SANA punishing the uncertainty that still lingers

0 · Reply

red1 May. 14 at 6:33 PM

$SANA anyone know why the volume is so high with real price movement?

2 · Reply

Harold2029 May. 14 at 6:28 PM

$SANA This should STILL be at least $30 …. The prospects of a remedy for Diabetes and its at: $3.10? You’ve GOT TO BE KIDDING ME!

0 · Reply

brut_2_3 May. 14 at 6:22 PM

1 · Reply

Harold2029 May. 14 at 5:41 PM

$SANA …. MAYO Clinic buying 15 million shares. Some analyst is predicting a 100x. Find a remedy for diabetes and you get the 100x. Im in! GLTA.

0 · Reply

FullTrust May. 14 at 2:01 PM

$SANA 20 mil vol hit tape at open So diluting or monster in the making

4 · Reply

FullTrust May. 14 at 1:34 PM

$SANA

0 · Reply

LoveRetailFroth May. 14 at 12:48 PM

$RXRX Good Morning ☕️ AI in healthcare is THE use case for AI. This & $TEM 💎 & $SANA $AMLX $SMMT

0 · Reply

mastergambler May. 14 at 11:47 AM

$SANA and the stock manipulation even more massive. Hopefully the scam is not massive too.

2 · Reply

BBraggHillBoys May. 14 at 12:10 AM

$SANA if successful, the upside is massive, but the scientific and operational complexity of this company is also massive.

0 · Reply

LoveRetailFroth May. 13 at 11:37 PM

$DGXX I bought 20k after averaging down @ 2.59 & I bought 95k of $VIVO @ 1.31 14 months ago. Good DEALS I guess🍺 Don’t sleep on $SANA & $RXRX $3 change today. It will be double digits by EOY. Pay those LT taxes! Secret to Real Wealth! GL!

1 · Reply

mastergambler May. 13 at 10:38 PM

$SANA probably just another scam, like 95% of WS tickers.

1 · Reply

Gemology May. 13 at 8:37 PM

$ACLS $EU $NFE $SANA $REI nature

0 · Reply

BriOnH May. 13 at 6:59 PM

$SANA 2 things to keep in mind: 1)Sana is the leader in hypoimmune. No one else has hypoimmune working in a human right now, only Sana does. 2)Vrtx with Lonza is the current leader in scaling islets for mass production. Will that change, will others catch up? Maybe, but right now this is where we are.

0 · Reply

mirko_papuga May. 13 at 6:54 PM

$SANA Picked up another 9,900 shares (lower than when I sold). SANA, we're going to change the world! Dealing with T1D for over 5 years, I can wait 5 months (100 trading days) until you launch the cure.

1 · Reply

BriOnH May. 13 at 6:52 PM

$SANA If Sana had to cut their prior programs because they didn't have enough money to pursue them in conjunction with their leading program sc451, why are they bringing on other programs again?

2 · Reply

mirko_papuga May. 13 at 6:33 PM

$SANA Oh SANA the market doesn't like you but I still love you. I believe in you!

0 · Reply

NotHopeJustFacts May. 13 at 4:58 PM

$SANA so now I remember, they're burning over 30M cash per Q and still have 100M thus in 3Q they will run out of money, and their pipeline is for Primates ? this is trash

1 · Reply

Market Cap	890.53M
Revenue (ttm)	0.00
Net Income (ttm)	-244.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	22,775,701
Avg Vol	3,674,628
Day's Range	N/A - N/A
Shares Out	278.29M
Stochastic %K	13%
Beta	2.17
Analysts	Strong Sell
Price Target	$8.57